Geistlich Local News - Special Edition 2021

AUSTRALIA AND NEW ZEALAND

Special Edition Calling for Clinical Cases

Share Your Clinical Case and Receive A Geistlich Clinical Satchel Minor Bone Augmentation

Major Bone Augmentation

Gain of Keratinised Tissue

Recession Coverage

Sinus Floor Elevation

Extraction Sockets

Periodontitis

SUBMIT

NOW!

THINK FRESH BILITATE

REGAIN - REGENERATE - REHA

Our Recent Live Hands-On Courses

Peri-implant Inflammation – A Real and Present Danger Treatment Options for Peri-implantitis 19 June 2021 Associate Professor Tino Mercado presented a contemporary update on peri-implantitis, an ever-increasing clinical issue which can often prove challenging to manage. The event took place at the Park Hyatt Hotel in Sydney and was attended by 10 clinicians.

The morning session comprised a series of didactic presentations examining current scientific understanding and management protocols for peri-implant inflammation. Tino presented an interesting treatment planning rubric based on scientific evidence and clinical experience. Based on this rubric, the main parameter dictating treatment is based on the percentage loss of bone over the time of implant service. Below a certain threshold percentage, explantation may be the recommended course of action. The afternoon session was conducted as a hands-on workshop using biomaterials, simulation models, and pig jaws to practice regeneration/reconstruction techniques. An essential part of peri-implantitis management is to sufficiently disturb the biofilm present on the exposed implant surface and then to effectively disinfect this surface. Biomaterials are then employed to help regenerate/reconstruct the affected peri-implant tissues.

Xenogeneic bone material (Geistlich Bio-Oss® and Geistlich Bio-Oss® Collagen) can be used to support new bone formation around the implant. A/Prof Mercado also demonstrated a newly developed technique utilising a porcine-derived volume stable collagen matrix (i.e. Geistlich Fibro-Gide®) to help reconstruct the

soft tissues around implants that have been affected by periimplantitis. Although no one particular treatment protocol for peri-implantitis has been scientifically proven to be superior, it does appear that newer treatment protocols and use of biomaterials can A/Prof Tino Mercado help adequately manage and even regenerate tissues compromised by peri-implant inflammation. The event was a success; plans are underway to conduct more workshops on this important topic throughout 2022. Please forward any expressions of interest to attend future workshops to your Geistlich Product Specialist.

Optimising Pink Aesthetics – Contemporary Approaches in SoftTissue Regeneration 30 July 2021 Adjunct Clinical Associate Professor Mehdi Valizadeh from Perth conducted a full-day workshop on the management of soft tissues around implants and natural teeth. The workshop took place at the Ritz Carlton Hotel in Perth, with 18 clinicians in attendance.

We are now starting to better appreciate the significance of soft tissue quantity, quality, and health on long-term success of prosthetic rehabilitations. Mehdi presented the scientific evidence justifying the need for ensuring sufficient width of keratinised tissues around teeth and implants. Available treatment options and treatment planning considerations were presented.

The use of xenogeneic collagen matrices to manage keratinised tissue deficiencies and gingival recessions was discussed and demonstrated on pig jaws. Attendees performed these procedures on pig jaws under the supervision of Mehdi, with an emphasis on flap design, manipulation, and achieving appropriate tension-free closure. Apical repositioning and coronal advancement flaps were demonstrated, as was the application of Geistlich Mucograft® Collagen. When aiming to gain keratinised tissue width, the 2

GEISTLICH SPECIAL EDITION 2021

Mucograft® was placed over exposed periosteum (split-flap raised) and sutured in position.

The overlying soft tissues were apically repositioned. In this manner, the Mucoraft® covers and protects the underlying soft tissues (open-healing) whilst stabilising the blood clot and encourage ingrowth of blood A/Prof Mehdi Valizadeh vessels and soft tissue cells.

Mehdi also discussed ways to minimise complications and ensure predictable outcomes. The attendees provided very positive feedback. We plan to conduct further soft tissue hands-on workshops around the country throughout 2022. Please forward any expressions of interest to attend future workshops to your local Geistlich Product Specialist so we can keep you informed of upcoming courses in your region.

Our Recent Live Hands-On Courses

Bone Defects and Soft Tissue Deficiencies – Contemporary Management Using Xenogeneic Materials 26 June 2021 Dr Steven Soukoulis, an experienced Adelaide-based periodontist, conducted a full-day workshop on the use of xenogeneic biomaterials to manage both hard and soft tissue deficiencies in the oral cavity. The workshop took place at the waterfront Henry Jones Art Hotel in Hobart. 13 clinicians were in attendance comprising of both general dental practitioners and specialist periodontists. Steven discussed the scientific rationale and justification for using different biomaterials for given clinical situations. With years of clinical experience in the field of oral regeneration, Steven demonstrated techniques that have worked well in his clinical practice. The afternoon session involved hands-on training whereby xenogeneic various biomaterials were applied to pig jaws simulating treatment of hard and soft tissue

deficiencies. A range of therapeutic areas were covered, including guided bone regeneration, (modified) socket preservation, and techniques for increasing soft tissue volume.

The feedback from the attendees was very positive and all enjoyed listening to Steven’s experiences and clinical knowledge.

Dr Steven Soukoulis

Introduction to Soft Tissue Management 15 September 2021 Clinical Associate Professor Mehdi Valizadeh conducted an on-line hands-on event featuring the novel #HOMEKIT which included the unique soft tissue mouth model designed in conjunction with Prof. Jonathon Leichter. This was the second iteration of the on-line hands-on training concept, this time focusing on the surgical management of soft tissue around natural teeth and implants.

Over 140 clinicians participated in this event, with registrations from Australia, New Zealand, Hong Kong, Vietnam, Singapore, the Philippines, and parts of Europe. Due to Covid-19 border travel restrictions, A/Prof Valizadeh was broadcasting from Perth, Dr George Alexopoulos (Clinical Science and Education Manager – Geistlich Pharma Australia) was moderating the event from Melbourne, and technical support was provided from Sydney and Adelaide. The course comprised of a 40-minute didactic presentation discussing the importance of, and scientific justification for, ensuring sufficient soft tissue quantity and

quality is present around teeth and implants. Two hands-on exercises were also presented, providing a step-by-step description on how the procedures are performed.

The first exercise focused on the gain of keratinised tissue width using an apical (re-) positioned flap combined with the use of A/Prof Mehdi Valizadeh a xenogeneic collagen matrix ® (Geistlich Mucograft ).

The second exercise demonstrated the management of a gingival recession defect (Miller's Class I or II) with Geistlich Mucograft® covered by a coronally advanced flap.

These are not necessarily simple procedures, and most of these procedures are performed in specialist surgical practice.

Nevertheless, this course provided a useful introduction to this important topic. Participants will now be in a better position to understand the importance of soft tissue management and to discuss this with their patients.

Furthermore, better quality referrals will be possible and for some participants, this interest may be fostered by additional face-toface training opportunities. The feedback from the participants was overwhelmingly positive, with nearly all suggesting they would recommend this course to their colleagues. A follow-up webinar was conducted on Wednesday the 29th of September which enabled Clin. A/Prof Mehdi Valizadeh and Dr George Alexopoulos to answer questions stemming from the course.

There is much demand for face-to-face training, and Geistlich is keen to conduct such courses in 2022.

3

Our Latest Fundraising Activity

Geistlich Pharma Australia & New Zealand is supporting the Royal Flying Doctor Service with a charity walk!

Similarly to last year, the Geistlich team participated in another good cause initiative following the company’s goal of improving the quality of life for people.

Geistlich Charity Walk & Run is an excellent activity for our team to join forces and raise much-needed funds for organisations which support our communities and help save lives.

This year, Geistlich Pharma Australia and New Zealand decided to support a local charity; one of the largest and most comprehensive aeromedical organisations in the world - “The Royal Flying Doctor Service”. The RFDS provides extensive primary health care and a 24-hour emergency service to people that live, work and travel across the 7.69 million square kilometres of Australia. Whether sunny or rainy, the RFDS helps over 1000 people every day and provides the very best medical care for those who don’t have ready access to doctors and hospitals.

4 SEPTEMBER 2021

YES, WE DID!

GEISTLICH ANZ ACHIEVED A TOTAL DISTANCE OF

176km

In the hope that with this support, the Royal Flying Doctor Service, which has been saving lives for over 90 years in rural and remote Australia, we have contributed to keeping them in the air.

The Geistlich Charity Walk & Run was held on 4th September 2021.

Our Latest Partnership

and

New Products Distributed by Geistlich Pharma Australia and New Zeal Geistlich Biomaterials, a world leader in regenerative dentistry, has specialised in regenerative medicine for over 30 years. Geistlich Bio-Oss® and Geistlich Bio-Gide®, the company's pioneer products, have contributed to the company being the global market leader in regenerative dentistry for many years.

With passion for perfection

Introducing high-end instruments that complement Geistlich's biomaterials portfolio was a logical next step. Spirited by the same philosophy and fuelled by "passion for perfection", Geistlich partnered with stoma® and became the exclusive distributor for Australia and New Zealand. From their HQ in Liptingen, Germany, stoma® has manufactured dental instruments of the highest quality since 1895.

For more details on the stoma instrument range please contact your local Geistlich Specialists or our customer service team on 1800 776 326.

4

GEISTLICH SPECIAL EDITION 2021

Our Current Activity

THINK FRESHHABILITATE

TE - RE REGAIN - REGENERA

Calling for Share Your Clinical Case October – November 2021

Geistlich's Clinical Pane

llists Lisa Heitz-Mayfield Professor Lisa Heitz-Mayfield, an Adelaide graduate, obtained a Master’s in periodontology (1996) and PhD (1998) from Lund University, Sweden. Her doctorate focused on periodontal and peri-implant regeneration. She received a scholarship to the Brånemark Osseointegration Centre, Sweden, and an ITI Scholarship to the University of Bern, Switzerland where she was Head of the Oral Microbiology Research Laboratory from 1999 to 2003. She was awarded the André Schroeder Research Prize in Implant Dentistry in 2002. Her positions include Adjunct Professor at the International Research Collaborative, University of Western Australia, Associate Professor at the University of Sydney, and Honorary Professor at the University of Hong Kong and the University of Notre Dame.

She is the Chair of the ITI Research committee and member of the Board of Directors of the International Team for Implantology. She was appointed Editor-in-Chief of the journal Clinical Oral Implants Research in 2016. Prof Heitz-Mayfield was elected as a member of the Board of Directors of The Osteology Foundation in 2018. She maintains a specialist periodontal practice in Perth.

Barbara Woodhouse Dr Barbara Woodhouse BDsc (hons MDSc MBBS FRACDS FFDRCS(Irel) FRACDS(OMS) FADI FICD FPFA is both a dental and medical practitioner who has practised in both rural and urban, public and private settings, and teaches and examines at undergraduate, graduate and post graduate levels in both disciplines, nationally and internationally. She is currently in specialist practice in Brisbane, practising the full scope of Oral and Maxillofacial Surgery from dentoalveolar, through orthognathic and head and neck surgery, including providing an extensive tertiary referral implant service. She is active on many hospital committees, general and specialist medical and dental societies, and sits on the board of the Royal Australasian College of Dental Surgeons

George Alexopoulos Dr George Alexopoulos graduated BDSc from The University of Melbourne in 1997 and worked in a variety of private and public dental settings. He was awarded an MBA from Monash University in 2003, a Masters of Science (Oral Implantology) from the J.W. Goethe University of Frankfurt in 2014, and a PhD from The University of Melbourne in 2021. Dr Alexopoulos has an interest in the fields of oral implantology and oral tissue regeneration. He is currently the Clinical Science and Education Manager for Geistlich Pharma Australia/New Zealand; a role that enables him to continue pursuing his interest in oral regeneration, research, and education. With years of clinical experience to draw upon, Dr Alexopoulos can be of assistance to both experienced and less experienced clinicians in their practice of implantology and oral regeneration.

Clinical Cases

Satchel al ic lin C h lic st ei G a e iv e c e R and Geistlich Pharma Australia and New Zealand is calling for your clinical cases!

Do you have a clinical case that you would like to share with your colleagues?

We invite you to share your clinical case with us for the opportunity to be published. Clinical cases must illustrate Geistlich biomaterials in one of the following therapeutic areas; Extraction Sockets – Minor Bone Augmentation – Major Bone Augmentation – Gain of Keratinised Tissue – Recession Coverage – Sinus Floor Elevation – Periodontitis.

Prof Lisa Heitz-Mayfield

All submitted cases will be evaluated by Geistlich’s clinical panellists, Prof Lisa Heitz-Mayfield, Dr Barbara Woodhouse and Dr George Alexopoulos, and the selected cases will be published in 2022*.

ence in

Our Sci

Barbara Woodhouse

Dr George Alexopoulos

ds

an Your H

Would you like YOUR clinical case to be published? tesstt ate Lat ions tio ati Publliiccaat

e of our best b h hee be th to tthe flectt to fle eeflec rrefl reflec refle d studies o re eed tted ite ite cited ttrryy to hee cited h we try th h we of tthe ugh ugggh u rss of ough o ou houg houg ho th hors hors llttthoug thors ttho Altho Al uthor aauth au h. A cch ich. ich hee autho lich. lich tlich. stlich st at the Geist G Ge th that issee that ssis d by Gei assise ed ted hasise hasis phasi rreeted reted rete prete rpr rpret empha erpre ntterpr n nterp it y emph itl a iinterp nss as e citly ex ions io tions ation We explic cati cation icatio blicat ublica ded d . We ded. fic publi ifi xclud tific ttifi ntific entifi b exclu cieenti scie sc of sscien nott be nnot nno ann anno ess of ies aaries ar er err s ccanno u ssum n summ ees,, error ain dies dies, tain udies tu studi contai conta ges con c ci cite pages pa he cited the th s. ngg pag in ing ies. ries. rries arie aries. aaries lowin nss off the marie ons on mma mm sio umm u usion us usi u hee follow the ssumm c con concl conc of th merrr: The d co im nd aim aime ai ntt of claim ent ten nttent ulltss and ults Diisclai Dis Disc Discl D onten o cont con co result res re e conte t the he h r th the or e fo f for ge dge blee edge ibl ible ledge sible wled wledg w nsible owled nowle ponsi kknow spo reesspons h respo ott be held not no anno an canno ca

th L

It is not uncommon for the mucogingival junction to be shifted in a coronal direction as a consequence of achieving primary wound closure over an augmented site. A second procedure is often required to apically reposition the dislocated mucogingival junction and to regain the necessary width of keratinised tissue to ensure a stable and aesthetic outcome. Geistlich Mucograft®, a purified porcine-derived collagen matrix, is a material wellsuited for this clinical application.

AT EST

Regain

PUB LICATIONS

As a token of appreciation, the Geistlich leather and fabric satchel will be given to every clinician who submits a clinical case. Ideal for your iPad or laptop, the satchel will contain Geistlich's latest clinical publications. To find out how to submit, contact your local Geistlich Product Specialist.

Geistlich Clinical

wi el h c Sat

Geistlich leather & fabric laptop satchel includes our latest clinical publications

Regenerate Following extraction of a tooth, the socket undergoes a process of repair.

Unfortunately this natural repair process often results in significant loss of horizontal and vertical dimensions of the ridge; as a consequence, there is some loss of the full potential of keratinised soft-tissue over the residual ridge. Use of appropriate xenogeneic biomaterials at the time of extraction (i.e. extraction socket management with Geistlich Bio-Oss® Collagen and Geistlich Mucograft® Seal) can help shift the process of repair to that of regeneration. The aim of therapy is to compensate for the loss of tissues occurring as part of the natural healing process (i.e. spontaneous healing) through use of biomaterials that support and stimulate new tissue formation.

Rehabilitate A goal of prosthetic dentistry is to successfully rehabilitate lost function and/or compromised aesthetics. Further to this point, this success needs to be sustained over the long-term. The presence of an adequate width of keratinised tissue around these rehabilitations is important to ensure gingival health and an aesthetic appearance that can be maintained. Geistlich Mucograft® provides an alternative material that can be employed in surgical procedures performed to enhance the width of keratinised mucosa. *Dental Magazines, Geistlich Microsite and Clinical Brochures.

7

Publisher ©Geistlich Pharma AG Subsidiary Australia / New Zealand The Zenith, Tower A, Level 21 821 Pacific Highway Chatswood NSW 2067, Australia Phone +61-(1)-800 776 326 Phone +64-(0)-800 500 043 Fax +61-(1)-800 709 698 Fax +64-(0)-800 500 044 www.geistlich.com.au www.geistlich.co.nz